Rothenberg, Mace L.
Brooke Army Medical Center,
United States
2025 Rank: 27206
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1189 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27206 | 32150 |
| Total Cites | 17710 | 18509 |
| H-index | 52 | 55 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 670 | 680 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 4106 | 4273 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 4798 | 5001 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15689 | 16269 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
4.32%
|
|
Rothenberg, Mace L.
Parthenon Therapeutics,
United States
2024 Rank: 25248
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1120 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25248 | 29166 |
| Total Cites | 17255 | 18028 |
| H-index | 51 | 53 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 660 | 670 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 4061 | 4229 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 4743 | 4948 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15256 | 15813 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
4.29%
|
|
Rothenberg, Mace L.
Pfizer Inc.,
United States
2023 Rank: 23800
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1080 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23800 | 27255 |
| Total Cites | 16850 | 17615 |
| H-index | 50 | 52 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 640 | 650 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 4001 | 4169 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 4666 | 4871 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14864 | 15416 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
4.34%
|
|
Rothenberg, Mace L.
Pfizer Inc.,
United States
2021 Rank: 20532
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 949 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20532 | 23878 |
| Total Cites | 15878 | 16611 |
| H-index | 49 | 50 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 610 | 619 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 3845 | 4009 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 4469 | 4670 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13963 | 14490 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.41%
|
|
Rothenberg, Mace L.
Pfizer Inc.,
United States
2020 Rank: 18389
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 910 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18389 | 21320 |
| Total Cites | 15217 | 15933 |
| H-index | 49 | 50 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 579 | 588 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 3747 | 3912 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 4368 | 4572 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13327 | 13831 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.49%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.